Last Updated: May 12, 2026

Details for Patent: 3,535,425


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,535,425
Title:1-chloro-2,2,2-trifluoroethyl difluoromethyl ether as an anesthetic agent
Abstract:
Inventor(s):Ross C Terrell
Assignee: Airco Inc , Anaquest Inc
Application Number:US886397A
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

What does US Patent 3,535,425 claim and how broad is the scope?

What is US 3,535,425 (bibliographic snapshot)?

US Patent 3,535,425 is a US “granted” patent with an associated claim set that defines enforceable scope in the United States. The user prompt does not provide the claims text, so a complete, claim-by-claim scope and landscape analysis cannot be produced from the information provided.

What are the claims?

The prompt ends at: “The claims are:” with no claim text following. Without the actual claim language, the claim scope cannot be accurately extracted or construed.

What is the scope if the claims are not provided?

Scope analysis in a patent landscape context depends on:

  • independent claim limitations (product, composition, method, use)
  • dependent claim fallbacks (narrowing features)
  • key terms that drive claim breadth (e.g., “comprising,” functional limitations, concentration ranges, structural Markush language)
  • priority/filing timeline and whether the claims track later improvements or cover earlier core subject matter

Those elements require the actual claim text.


What is missing to complete the patent landscape for US 3,535,425?

A full “scope and claims” analysis and a credible US patent landscape requires, at minimum, these inputs:

  • the full claim set (independent and dependent claims) as actually granted
  • the assignee/inventor and publication data (to anchor prosecution history and citation graph)
  • citation set (patents and non-patent literature cited during prosecution)
  • the patent family status and continuation activity (to map surrounding protection)

The message provides none of that.


Claim-anchored landscape mapping (cannot be completed)

A proper landscape is built by linking:

  • claim elements (what is protected) to
  • prior art (what limits novelty/obviousness) and to
  • competing molecules/compositions/processes (who designs around)

Without the claims text, no element-level mapping can be performed, and no valid landscape can be generated.


Key Takeaways

  • A complete scope and claims analysis for US Patent 3,535,425 cannot be produced because the prompt does not include the claims text after “The claims are:”.
  • A credible patent landscape also cannot be generated from the provided information because no bibliographic identifiers, claim language, or citation data are included.

FAQs

  1. Can you analyze claim scope without the claim text? No. Claim scope analysis requires the exact granted claim language.
  2. Can you infer claims from the patent number alone? Not with the constraint that the response must be complete and accurate.
  3. Does a landscape depend on claim language? Yes. Landscapes are element-based, not just patent-number-based.
  4. Can you summarize potential competitors without claims? Not reliably; design-around strategies depend on which limitations control.
  5. What would enable a full analysis? The full granted claims plus bibliographic and citation metadata.

References

[1] None provided in the prompt.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 3,535,425

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.